1. Technical Analysis and Prediction for Sarepta Therapeutics, Inc. (SRPT)

A. Long-Term Context and Recent Price Dynamics

SRPT shows an exceptionally high volatility environment over the last several months. The share price was above $70 in March 2025 before cascading through a near relentless downtrend, with occasional dead cat bounces, to close at $14.08 on July 18. The most recent session (July 18) saw an enormous range—open $16.98, high $19.18, low $12.81, closing at $14.08—on staggering volume (76,858,200 shares). The prior day, there was a dramatic surge (open $22.54, high $22.86, low $20.94, close $21.97) on 19,730,500 shares. The collapse that happened on July 18th marks at least a >30% daily decline, indicative of either a major negative fundamental catalyst (such as regulatory setback, failed clinical trial, or poor earnings) or a broad market panic. High-frequency intraday data confirms a further drop into the $13-$14 area after the close.

B. Trend Analysis

• Downtrend Identified: The mid/long-term trend is unambiguously bearish. After a sustained decline from the $70s, SRPT had several brief rallies (near $38-$43 in June and early July), but each was violently rejected, suggesting persistent selling pressure.
• Momentum Shift Confirmation: The colossal one-day drop on July 18 wipes out multiple weeks of price support; volume confirms capitulation selling.

C. Candlestick and Chart Pattern Analysis

• Capitulation Bar: July 18 is a giant bearish engulfing bar, or even a potential “gap down” exhaustion move. The sheer range and volume likely signify forced liquidations.
• Support Breach: Price action annihilated all June and July lows. Intraday candle structure isn’t showing immediate buyback strength (close near lows, weak afterhours action).

D. Volume Profile Assessment

• Climactic Volume: Volume is 3-4x typical daily average; this is a classic sign of a capitulation event.
• Post-Climax Absence of Bullish Reversal: Frequently capitulation is followed by a short-term bounce, but initial afterhours and closing prices show no sign of strong recovery.

E. Gap and Price Levels

• Gap Below Support Levels: The price gap from $22 to $14 is massive and leaves a large vacuum of previous trading interest. Next technical support deals with 2016-2017 trading ranges near $12—SRPT is now at multiyear lows.

F. Moving Averages and Indicator Analysis

• SMA/EMA (Assumed 10, 20, 50, 200): Even without exact values, all logical moving averages—short and long-term—are dramatically above current market price, reinforcing an extreme oversold condition but also showing no trend support below.
• RSI: Expected to be sub-20, deep in oversold territory. However, after major catalyst events, oversold/overbought signals can remain in place for an extended period and are unreliable for automatic reversal trading right now.
• MACD: Would show a massive bearish cross and negative histogram expansion, aligning with momentum collapse.

G. Order Flow and Liquidity Structure

• Order Imbalance: Given the abruptness and size of the drop alongside extreme volume, the order book is likely to remain thin and illiquid at current levels; further volatility should be anticipated.

H. Support/Resistance Zones

• Resistance: $18 (recent breakdown), $22 (gap top), $24+ (pre-gap levels)
• Support: $12.80 (intra-day low July 18), $11–12 (historic long-term). Absent clear support above, risk of further drift lower is non-trivial.

I. Statistical/Volatility Models

• ATR: Recent ATR (average true range) must be among the highest historically. Range in a single session exceeding $6 ($19.18-$12.81) demonstrates 40–50%+ daily vol; not normal.
• Bollinger Bands: Price is stampeded through the lower band, suggesting oversold, but bands themselves likely expanding rapidly due to volatility spike.

J. Sentiment and Behavioral Analysis

• Investor Sentiment: Panic and forced selling are dominant. Flows from institutions, retail, and perhaps index funds reducig/covering positions. Given no signs of buying support, catching a falling knife is extremely risky.
• Possible Dead Cat Bounce? Short covering and technical bargain-hunting could drive a brief bounce, but the scale of the price damage argues for more digestion before stability forms.

K. Catalyst and Event Risk

• Major Event Impact: Such extreme moves only occur after material events. Unless and until clarity emerges (FDA, earnings, lawsuits, management update), headline risk remains skewed lower.

---

Synthesis: Strategic Decision

• Probability-Weighted Outcome: Most likely short-term scenario (next 24 hours) is continuation or retest of intraday lows ($12.80–$13.50) with high tail risk for further downside, especially without any sign of reversal in price or volume in the closing/after-market session.
• Risk/Reward for Long: Although deeply oversold, the risk of further immediate downside outweighs the potential for a technical bounce. There is also the psychological impact of a broken floor; prior supporters may capitulate further.
• Short-Selling Edge: For seasoned, nimble traders, a short position opened on a weak bounce toward $14.30–$14.50 offers the best risk/reward, targeting a retest of Friday’s low ($12.80) or new low print. Tight stops above breakdown levels are needed given volatility.

Decision: SELL (Short Position)

---

Entry: Open Short Near $14.30

• Rationale: Entering if a minor bounce appears post-capitulation. Allows for best reward in next session. If price simply opens lower, be cautious—avoid shorts < $13.30.

Target: Close Short at $12.90

• Rationale: Next logical support is near Friday’s low ($12.81), so $12.90 provides high probability exit ahead of possible bid.

Only aggressive speculators should attempt this trade. Tighten stop if price closes above $15 intraday.

---